News
Research suggests women with high breast cancer risk and menopausal symptoms could benefit from Duavee, which reduced breast tissue cell growth in a Northwestern University study.
3d
MedPage Today on MSNNon-Hormonal Drug Reduced Hot Flashes From Endocrine Therapy for Breast CancerCHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...
A vegan diet rich in soy reduced severe hot flashes by 92% in postmenopausal women, according to a new study published in ...
Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...
2d
Flow Space on MSNA New Option for Hot Flashes: What the Research Says About ElinzanetantHot flashes happened less often and were less severe in women who took elinzanetant compared to those who took a placebo. The ...
Primary and review articles published in English were identified by a MEDLINE (1966-June 2003) search using the MeSH terms "hot flashes," "hot flushes," "menopause," and "serotonin reuptake inhibitor.
Vasomotor symptoms, such as hot flashes, are widely recognized, but there are dozens of other menopausal symptoms that a woman can experience. Not All Menopausal Symptoms Are the Same, in Terms of ...
ADHD is often thought of as a children’s condition, but research indicates that around 4.4 percent of American adults have ADHD. Adults with ADHD may see their symptoms fluctuate over time. Some ...
In December, the U.S. Food and Drug Administration (FDA) approved a new treatment for people with insomnia, Dayvigo (lemborexant). The drug will be available in 5 or 10 milligram (mg) doses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results